Key result
Robotic pancreaticoduodenectomy in obese patients was associated with longer operation times (9.5 vs 7.5 hours) compared to non-obese patients, but had comparable surgical mortality and morbidity.
Why the study?
The impact of obesity on perioperative outcomes in robotic pancreaticoduodenectomy is rarely documented.
Does obesity negatively impact perioperative outcomes in patients undergoing robotic pancreaticoduodenectomy compared to non-obese patients or open surgery?
Observational (n=886)
Does obesity negatively impact perioperative outcomes in patients undergoing robotic pancreaticoduodenectomy compared to non-obese patients or open surgery?
Answers are grounded in this paper and cite their sources.
Obesity does not negatively impact perioperative outcomes in robotic pancreaticoduodenectomy other than prolonging operation time, making it a safe approach for obese patients.
BACKGROUND: The aim of this study is to assess the impact of obesity on the perioperative outcomes in robotic pancreaticoduodenectomy (RPD), rarely documented. METHODS: A total of 886 patients undergoing RPD or open pancreaticoduodenectomy (OPD) were enroled. These patients were categorised into the obese RPD, non-obese RPD and obese OPD groups. RESULTS: Operation time was longer in obese RPD compared with non-obese RPD and obese OPD (median: 9.5 vs. 7.5 and 8.0 h). Blood loss was lower in both RPD groups than in the obese OPD group (median: 200 and 120 vs. 500 c.c.). Surgical mortality and morbidity were comparable between these three groups. Delayed gastric emptying (DGE) occurred less frequently in both RPD groups than obese OPD (7.5% and 4.4% vs. 19.1%). CONCLUSIONS: Obesity does not exert a negative impact on the perioperative outcomes in RPD, except for longer operation times. RPD has emerged as a safe and viable surgical approach for obese patients.
No takes yet. Share an insight, caveat, or question.
Shyr et al. (2024) conducted an observational in Pancreaticoduodenectomy (n=886). Robotic pancreaticoduodenectomy in obese patients vs. Non-obese robotic pancreaticoduodenectomy and obese open pancreaticoduodenectomy was evaluated on Perioperative outcomes (operation time, blood loss, mortality, morbidity, delayed gastric emptying). Robotic pancreaticoduodenectomy in obese patients was associated with longer operation times (9.5 vs 7.5 hours) compared to non-obese patients, but had comparable surgical mortality and morbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: